Mr. Speaker, I thank the hon. member for delivering such an eloquent speech on Bill C-51.
She explained very clearly a number of problems that are found in this legislation. I wonder if she could tell us more on the issue of drug advertising which, under the bill, would be authorized to a much greater extent than is currently the case. The fact is that this already creates a problem.
I would also like her to tell us a bit about the fact that the minister would really have a great deal of latitude to decide by himself whether he wants to change the thrust of the bill, or whether he is prepared to keep it as reviewed and probably amended by the Standing Committee on Health,.
I wonder if the hon. member could give us her thoughts on this.